Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Food Safety News (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Travel abroad linked to large share of infections in English region

% of readers think this story is Fact. Add your two cents.


International travel is a major risk factor for developing a range of infections, according to a study in a region of England.

Scientists found illness after travel abroad contributes substantially to the burden of infection in North East England. There has also been no reduction in the proportion of travel-associated infections in non-pandemic years since 2013. 

Laboratory reports of common notifiable enteric infections were linked to exposure data for cases reported between January 2013 and December 2022. Results were published in the journal Epidemiology and Infection.

Pathogens behind illness
In total, 9,358 lab-confirmed cases of gastrointestinal illness resulting from infection with Cryptosporidium, Giardia, hepatitis A, Salmonella, Shigella, Shiga toxin-producing E. coli (STEC), Vibrio, and Yersinia were reported in North East England residents. Routine exposure questionnaires were completed for 7,909 cases.

About 35 percent of cases reported international travel during their incubation period, although travel-associated cases were significantly reduced during the COVID-19 pandemic.

Between 2013 and 2019, half of Shigella and non-typhoidal Salmonella infections and a third of Giardia infections were reported following travel. The figure was under 30 percent for Cryptosporidium and above 20 percent for STEC infections.

In England, all lab-confirmed cases of notifiable enteric infections are reported to the UK Health Security Agency (UKHSA) from National Health Service (NHS) labs via the Second-Generation Surveillance System (SGSS). North East England has its own surveillance system, which links routinely collected SGSS data, lab typing data, and exposure data from standardized exposure questionnaires. 

Cases were defined as being associated with international travel if they had a completed exposure questionnaire and reported going outside the UK during a specified incubation period. The proportion of cases associated with international travel remained consistent between 2013 and 2019 with an average of 38 percent.

During England’s COVID-19 pandemic response in 2020 and 2021, infections were much lower than historic figures. In 2022, reports returned to pre-pandemic levels, mainly because of increases in travel-associated cases.

Risky destinations
The percentage of cases associated with travel remained consistent for most pathogens apart from Shigella, where a rise in UK-acquired cases has been observed since 2013, and STEC O157, where an increase in internationally acquired cases was reported in 2019.

Children aged under 9 and adults over 60 were significantly more likely to have acquired their infection in the UK.

Where such data was available, those of Asian ethnicity were more likely to have acquired their infection during international travel, with the rate of reported travel-associated infection in those of Asian ethnicity significantly higher than the rate for those of White ethnicity.

The most common destination reported by cases was Spain, followed by Turkey, India, and Egypt. Rates of illness were highest in people returning from Africa and Asia, with high rates also associated with all-inclusive tourist resorts like Turkey, Egypt, and the Dominican Republic.

Rates of hepatitis A and typhoidal Salmonella were highest in travelers to Asia, and rates of Vibrio were comparable for travelers to both Africa and Asia. Rates for all other pathogens were highest in people returning from Africa. The rate of acquiring non-typhoidal Salmonella was 527 times higher in travelers to Asia when compared to travelers to Europe.

More than 50 Salmonella and 41 Cryptosporidium clusters were identified. Salmonella outbreaks were mostly linked to travel to Turkey, Egypt, and Mexico. Cryptosporidium outbreaks were predominantly associated with Spain, Turkey, the Canary Islands, and Egypt.

“This work highlights the need to better understand risks while traveling to support the implementation of guidance and control measures to reduce the burden of illness in returning travelers,” said researchers.

(To sign up for a free subscription to Food Safety News, click here.)


Source: https://www.foodsafetynews.com/2024/08/travel-abroad-linked-to-large-share-of-infections-in-english-region/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.